Powered by a vision
Aspect Medical systems is powered by a vision; to help medical professionals deliver the best possible patient care by providing brain monitoring technologies that enhance clinical decision making.
Technology for today and tomorrow.
Today, our BIS systems help confirm the level of consciousness of the anesthetized or sedated patient in a variety of clinical settings. Tomorrow, extensions of this advanced technology may bring greater understanding to the treatment of disease of the brain.
New research to help diagnose neurological diseases
In November 2001, Aspect established a Neuroscience division to further leverage the company's new expertise, with the goal of developing technologies that can help detect and diagnose neuro-based diseases.
Aspect is investigating a wide range of brain-based disorders, including depression and Alzheimer's disease.
Leadership
The Neuroscience division within Aspect is led by Philip Devlin, Vice President and General Manager of Neuroscience. Mr. Devlin helped spearhead the research and pioneered the initial applications for BIS monitoring.
Andrew F. Leuchter, M.D., Professor and Vice Chair, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, David Geffen School of Medicine at UCLA, serves as Chair of Aspect's Neuroscience Scientific Advisory Board.
Learn more about Aspect's Neuroscience division through our Neuroscience Press Releases and Presentations:
- 5/22/06 – Aspect Antidepressant Response Index Accurately Predicts Patient Response To SSRI’s After One Week On Medication
- 7/19/06 - Results From Aspect’s Cape Cod Memory Study Presented At The International Conference On Alzheimer’s Disease And Related Disorders
- 12/11/06 – Aspect Medical Systems Announces Progress of BRITE Major Depression Study
- 5/21/07 – Aspect Medical Systems Announces Interim Results of BRITE Major Depression Study at Annual Meeting of the American Psychiatric Association
- 6/11/07 – Aspect Medical Systems Reports Interim Results from Two Ongoing Mild Cognitive Impairment and Alzheimer's Disease Studies
- 6/11/07 – Aspect Medical Systems Initiates Share Repurchase from Boston Scientific and Announces Conclusion of Neuroscience Alliance
